We introduce DEARGEN’s research results on the model that predicts the primary cancer sites (cancer metastasis prediction) through the gene expression profile (GEP).
Read More
Prediction of origin of cancer by deep-learning analysis using pan-cancer transcriptome
유전자 발현량 (GEP)를 보고, 암 원발부위를 예측(암 전이 예측)하는 모델에 대한 디어젠의 연구 결과를 소개합니다.
Read More
CWx (Cascaded Wx): Technology for Prognosis Biomarker Discovery
Deargen has announced the research results on an AI technology CWx that can discover biomarkers on disease prognosis. The research achievements has been published in the journal Frontiers in Genetics.
Read More
WX: Technology for Novel Biomarker Discovery
Deargen has announced research results on an AI technology Wx that can discover novel biomarkers. Research achievements are being published in the journal of the Nature Scientific Report, and two inventions related to these have been patented.
Read More
WX : Novel 바이오마커 발굴 기술
디어젠(주)는 새로운 바이오마커를 발굴할 수 있는 AI기술 Wx에 대한 연구성과를 발표했습니다. 연구 성과는 Nature Scientific Report 저널에 게재되어 있으며, 이와 관련 된 2개의 특허를 출원 했습니다.
Read More
Deargen, Selected for the TIPS Program with Genomic Data Analysis Service
Deargen was selected for the TIPS program, so it will receive a total of $600,000 in R & D expenses from the operator Medytox Venture Investment.
Read More
디어젠, 유전체 데이터 분석 서비스를 통한 TIPS 프로그램 선정
TIPS 프로그램에 디어젠이 선정되어 운영사 메디톡스 벤처투자로부터 총 7억 원의 연구개발(R&D)비용을 지원받게 되었습니다.
Read More
Genomic Data Analysis Platform ‘DearTRANS’ Beta Service Launch
Deargen launches a beta service of ‘DearTRANS’ that is a cloud-based genomic big data analysis platform that the world’s first artificial intelligence technologies are applied.
Read More
유전체 데이터 분석 플랫폼 ‘디어트렌스(DEARTRANS)’ 베타 서비스 오픈
디어젠이 세계 최초 인공지능 기술을 적용한 클라우드 기반의 유전체 빅데이터 분석 플랫폼’디어트렌스(DEARTRANS)’의 베타 서비스를 시작합니다.
Read More
The Challenge to Conquer Cancer, Prognostic Prediction Analysis of Lung Cancer Using AI
Deargen has been selected for the 2017 National Program for Cancer Control that is hosted by the Ministry of Health and Welfare and the National Cancer Center. Deargen will develop an integrated prognostic analysis model of lung cancer using artificial intelligence by collaboration with St. Mary’s Hospital and Dankook University.
Read More